China Medical System Holding Stock price
Compare with Peer Group
Is China Medical System Holding a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,133 stocks worldwide.
Key metrics
China Medical System Holding Stock Analysis
Analyst Opinions
14 Analysts have issued a China Medical System Holding forecast:
Analyst Opinions
14 Analysts have issued a China Medical System Holding forecast:
Don't miss a Thing! We will send you all news about China Medical System Holding directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
China Medical System Holding Stock News
Company Profile
China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. The company employs 6,415 full-time employees The company went IPO on 2010-09-28. The firm's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The firm distributes its products within domestic market and to overseas markets.
| Head office | Cayman Islands |
| CEO | Mr. Lam |
| Employees | 6,415 |
| Website | web.cms.net.cn |


